With possible future applications in space missions
(ANSA) – BUENOS AIRES, NOV 23 – The European Space Agency (ESA) and Argentina today signed a memorandum of understanding in Buenos Aires to extend the experimentation in the Argentine bases in Antarctica for the period 2021-2022 (Belgrano II and Carlini) of a telemedicine device, called Tempus Pro, also in view of its future use in European space missions.
In a press conference, attended by the other heads of ESA and the Argentine National Space Commission (Conae), and the Ambassador of the European Union (EU) in Buenos Aires, Amador Sánchez Rico, the Undersecretary for Foreign Affairs for the Malvinas, Antarctica and the South Atlantic, Guillermo Carmona, underlined the value of the agreement which has “a high scientific and technological value”, and which “will allow the experimentation of telemedicine in the particular Antarctic environment”, which is quite similar to what exists in planets that are possible targets of human activity in space.
The Tempus Pro portable device has long been used by doctors all over the world to remotely and in real time measure parameters such as heart rate, blood pressure, respiratory rate and temperature of a patient, also allowing voice communication between a doctor and the staff of the listening place.
The experimentation of Tempus Pro in Antarctica began in 2020, after the signing of a first memorandum by the National Antarctic Directorate (Dna), ESA and Conae in November 2019. (ANSA).